INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Trevor Mundel—President, Global Health, Bill & Melinda Gates Foundation—Why we invest in innovation

Trevor Mundel—President, Global Health, Bill & Melinda Gates Foundation—Why we invest in innovation

Or, how we managed to bamboozle the world to make a fortune from SARS-CoV-2 injections

Hedley Rees's avatar
Hedley Rees
Jan 11, 2025
∙ Paid
20

Share this post

INSIDE PHARMA
INSIDE PHARMA
Trevor Mundel—President, Global Health, Bill & Melinda Gates Foundation—Why we invest in innovation
3
6
Share

Share

Why we invest in innovation

The article Why we invest in innovation dated October 2020, was written by Trevor Mundel of BMGF infamy. This is him from a previous Inside Pharma post in 2022:

Ex-Novarits global head of development working for #GatesFoundationCrooks for 10+ years

Ex-Novarits global head of development working for #GatesFoundationCrooks for 10+ years

Hedley Rees
·
November 27, 2022
Read full story

This article begins:

Imagine a world where millions of babies in remote and rural areas survive childbirth because their mothers got an ultrasound via their smartphone, or where the brutal disease known as “bonecrusher fever” is under control because mosquitoes have been inoculated with a bacteria that prevents them from transmitting it.

How about a world where vaccines can easily travel anywhere because of portable and power-free cold storage? Or one where children are getting precisely the correct amount of different nutrients? That’s because health professionals can gently insert a tiny camera through a child’s nose, see exactly what’s going on inside their digestive system, and use the information to restore the power of their gut.

Well, I’d say “imagine a world where a technology geek with an affini…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share